Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_assertion type Assertion NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_head.
- NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_assertion description "[However, when determining merlin and ezrin in ovarian carcinoma cells, we have observed that both merlin and ezrin could be over-expressed simultaneously in some ovarian cancer (OVCA) cell lines and OVCA ascites cells, suggesting that merlin could be an oncoprotein rather than a tumor suppressor protein in certain OVCA cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_provenance.
- NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_assertion evidence source_evidence_literature NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_provenance.
- NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_assertion SIO_000772 16824698 NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_provenance.
- NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_assertion wasDerivedFrom befree-20140225 NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_provenance.
- NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_assertion wasGeneratedBy ECO_0000203 NP447108.RAHBAMdMejpAQ6-2s_Tsxv-IL3sh79ijKn6nWdJPNoNZk130_provenance.